Home > Insider Trading > Filing (0001209191-20-057506)

Filing Details

Accession Number:: 0001209191-20-057506
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-11-09 19:06:14
Reporting Period:: 2020-11-05

Accepted Time:: 2020-11-09 19:06:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1679363	Morphic Holding Inc.	MORF	Pharmaceutical Preparations (2834)	473878772

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1779978	P. Praveen Tipirneni	C/O Morphic Holding, Inc. 35 Gatehouse Drive, A2 Waltham MA 02451	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-11-05	6,643	$4.32	9,929	No	4	M	Direct
Common Stock	Disposition	2020-11-05	6,643	$26.85	3,286	No	4	S	Direct
Common Stock	Disposition	2020-11-05	6,525	$26.85	653,400	No	4	S	Indirect	By The Praveen P. Tipirneni Irrevocable Trust of 2019
Common Stock	Acquisiton	2020-11-06	4,367	$4.32	7,653	No	4	M	Direct
Common Stock	Disposition	2020-11-06	4,367	$26.14	3,286	No	4	S	Direct
Common Stock	Disposition	2020-11-06	4,331	$26.13	649,069	No	4	S	Indirect	By The Praveen P. Tipirneni Irrevocable Trust of 2019
Common Stock	Acquisiton	2020-11-09	2,508	$4.32	5,794	No	4	M	Direct
Common Stock	Disposition	2020-11-09	2,508	$27.61	3,286	No	4	S	Direct
Common Stock	Disposition	2020-11-09	2,595	$27.66	646,474	No	4	S	Indirect	By The Praveen P. Tipirneni Irrevocable Trust of 2019

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Indirect	By The Praveen P. Tipirneni Irrevocable Trust of 2019
No	4	M	Direct
No	4	S	Direct
No	4	S	Indirect	By The Praveen P. Tipirneni Irrevocable Trust of 2019
No	4	M	Direct
No	4	S	Direct
No	4	S	Indirect	By The Praveen P. Tipirneni Irrevocable Trust of 2019

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy Common Stock)	Disposition	2020-11-05	6,643	$0.00	6,643	$4.32
Common Stock	Stock Option (right to buy Common Stock)	Disposition	2020-11-06	4,367	$0.00	4,367	$4.32
Common Stock	Stock Option (right to buy Common Stock)	Disposition	2020-11-09	2,508	$0.00	2,508	$4.32

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
440,333	2028-12-14	No	4	M	Direct
435,966	2028-12-14	No	4	M	Direct
433,458	2028-12-14	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.44 to $27.22 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.44 to $27.08 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
These securities are held of record by Sonali N. Shah, Trustee of The Praveen P. Tipirneni Irrevocable Trust of 2019. The reporting person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.89 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.13 to $28.00 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.29 to $28.00 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vests as to 2.0833% of the total shares monthly, beginning January 14, 2019, with 100% of the total shares vested and exercisable on December 14, 2022, subject to the reporting person's provision of service to the issuer on each vesting date.